Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study

1. Abrisqueta, P.
2. González-Barca, E.
3. Panizo, C.
4. Pérez, J.M.A.
5. Miall, F.
6. Bastos-Oreiro, M.
7. Triguero, A.
8. Banerjee, L.
9. McMillan, A.
10. Seymour, E.
11. Hirata, J.
12. de Guzman, J.
13. Sharma, S.
14. Jin, H.Y.
15. Musick, L.
16. Diefenbach, C.